Онкологија
Лечење неутропеније
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. (отвара нови прозор)
Извор: Eur J Cancer 2011;47(1):8-32.
Индекс: PubMed 21095116
DOI: 10.1016/j.ejca.2010.10.013
https://www.ncbi.nlm.nih.gov/pubmed/21095116 (отвара нови прозор)
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. (отвара нови прозор)
Извор: Clin Infect Dis 2011;52(4):427-31.
Индекс: PubMed 21205990
DOI: 10.1093/cid/ciq147
https://www.ncbi.nlm.nih.gov/pubmed/21205990 (отвара нови прозор)
High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors. (отвара нови прозор)
Извор: Leuk Lymphoma. 2019;60(9):2324-7.
Индекс: PubMed 30773115
DOI: 10.1080/10428194.2019.1577414
https://www.ncbi.nlm.nih.gov/pubmed/30773115 (отвара нови прозор)
Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice Guideline Update. (отвара нови прозор)
Извор: J Clin Oncol 2015;33(28):3199-212.
Индекс: PubMed 26169616
DOI: 10.1200/JCO.2015.62.3488
https://www.ncbi.nlm.nih.gov/pubmed/26169616 (отвара нови прозор)